IRE Elit and Isologic announce the approval of the Gallium-68 generator, Galli Eo®, as a drug in Canada
December 5th, 2019 – Fleurus, Belgium & Montreal, Canada: IRE ELIT, Belgian radiopharmaceutical company, has just received the Notice of Compliance (NOC) from Health Canada for its drug Galli Eo, the generator of Germanium/Gallium-68; which until now had a type II Drug Master File
